- Home
- ATNM vs DALN Comparison
ATNM vs DALN Comparison
Compare ATNM & DALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNM
- DALN
- Stock Information
- Founded
- ATNM 2000
- DALN 1954
- Country
- ATNM United States
- DALN United States
- Employees
- ATNM N/A
- DALN N/A
- Industry
- ATNM Biotechnology: Pharmaceutical Preparations
- DALN Newspapers/Magazines
- Sector
- ATNM Health Care
- DALN Consumer Discretionary
- Exchange
- ATNM Nasdaq
- DALN Nasdaq
- Market Cap
- ATNM 46.5M
- DALN 38.1M
- IPO Year
- ATNM N/A
- DALN 2008
- Fundamental
- Price
- ATNM $1.61
- DALN $4.56
- Analyst Decision
- ATNM Strong Buy
- DALN
- Analyst Count
- ATNM 4
- DALN 0
- Target Price
- ATNM $8.75
- DALN N/A
- AVG Volume (30 Days)
- ATNM 1.3M
- DALN 50.1K
- Earning Date
- ATNM 04-25-2025
- DALN 03-17-2025
- Dividend Yield
- ATNM N/A
- DALN N/A
- EPS Growth
- ATNM N/A
- DALN N/A
- EPS
- ATNM N/A
- DALN 0.02
- Revenue
- ATNM $81,000.00
- DALN $125,391,000.00
- Revenue This Year
- ATNM $138.42
- DALN N/A
- Revenue Next Year
- ATNM $16,957.05
- DALN N/A
- P/E Ratio
- ATNM N/A
- DALN $235.00
- Revenue Growth
- ATNM N/A
- DALN N/A
- 52 Week Low
- ATNM $1.03
- DALN $2.98
- 52 Week High
- ATNM $10.24
- DALN $7.86
- Technical
- Relative Strength Index (RSI)
- ATNM 59.52
- DALN 27.68
- Support Level
- ATNM $1.66
- DALN $5.20
- Resistance Level
- ATNM $2.41
- DALN $6.31
- Average True Range (ATR)
- ATNM 0.22
- DALN 0.49
- MACD
- ATNM 0.05
- DALN -0.17
- Stochastic Oscillator
- ATNM 37.60
- DALN 4.85
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
About DALN DallasNews Corporation Series A
DallasNews Corp is a local news and information publishing company in Texas with commercial printing, distribution, and direct mail capabilities, as well as a presence in emerging media and digital marketing.